Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 3Completed 3Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 370Lymphoma, Non-Hodgkin 348Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Lymphoma, Large B-Cell, Diffuse 244Lymphoma, Follicular 236Leukemia 198Hodgkin Disease 171Lymphoma, Mantle-Cell 164Leukemia, Myeloid, Acute 160Multiple Myeloma 134Myelodysplastic Syndromes 130Recurrence 125Burkitt Lymphoma 123Lymphoma, B-Cell, Marginal Zone 120Lymphoma, T-Cell, Cutaneous 92Neoplasms 82Mycosis Fungoides 82Lymphoma, B-Cell 82Waldenstrom Macroglobulinemia 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 70Sezary Syndrome 67Lymphoma, Large-Cell, Immunoblastic 65Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 57Lymphoma, Large-Cell, Anaplastic 54Neoplasms, Plasma Cell 52Myeloproliferative Disorders 52Primary Myelofibrosis 46Hematologic Neoplasms 44Blast Crisis 43

Interventions

tirabrutinib 1obinutuzumab 1idelalisib 1Influenza Vaccines 16-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × B-cell Malignancies × Lymphoid × Clear all
NCT02457598 2025-06-17

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies

Gilead Sciences

Phase 1 Terminated
203 enrolled 43 charts
Lymphoid

B-cell Malignancies

NCT03701438 2020-02-20

Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib

Gilead Sciences

Terminated
2 enrolled
Lymphoid

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡